These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6547778)

  • 21. Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis.
    Mucha SM; deTineo M; Naclerio RM; Baroody FM
    Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):164-72. PubMed ID: 16490874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A double-blind, placebo-controlled study on the efficacy of Rinasek in symptomatic treatment of seasonal and non-seasonal rhinitis].
    Udovicki J; Milosevic D; Popov-Dragin O
    Med Pregl; 1995; 48(7-8):255-9. PubMed ID: 8524201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of single and multiple doses of pseudoephedrine in the treatment of nasal congestion associated with common cold.
    Eccles R; Jawad MS; Jawad SS; Angello JT; Druce HM
    Am J Rhinol; 2005; 19(1):25-31. PubMed ID: 15794071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double-blind assessment of azelastine in the treatment of perennial allergic rhinitis.
    Grossman J; Halverson PC; Meltzer EO; Shoenwetter WF; van Bavel JH; Woehler TR; Freitag JJ; Hemsworth GR
    Ann Allergy; 1994 Aug; 73(2):141-6. PubMed ID: 8067597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antihistaminic therapy of chronic urticaria. Results of a multicenter study with azatadine and terfenadine].
    Neumann Y
    Fortschr Med; 1984 Oct; 102(38):967-70. PubMed ID: 6209194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loratadine/pseudoephedrine for nasal symptoms in seasonal allergic rhinitis: a double-blind, placebo-controlled study.
    McFadden EA; Gungor A; Ng B; Mamikoglu B; Moinuddin R; Corey J
    Ear Nose Throat J; 2000 Apr; 79(4):254, 257-8, 260 passim. PubMed ID: 10786387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of an antihistamine-pseudoephedrine drug on the blood pressure of moderate hypertensives.
    Greening GK
    Curr Ther Res Clin Exp; 1969 May; 11(5):252-5. PubMed ID: 4977395
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevalence and predictors of respiratory symptoms among New York farmers and farm residents.
    Gomez MI; Hwang SA; Lin S; Stark AD; May JJ; Hallman EM
    Am J Ind Med; 2004 Jul; 46(1):42-54. PubMed ID: 15202124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiofrequency for the treatment of allergic rhinitis refractory to medical therapy.
    Lin HC; Lin PW; Su CY; Chang HW
    Laryngoscope; 2003 Apr; 113(4):673-8. PubMed ID: 12671427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nasal decongestant activity of pseudoephedrine.
    Roth RP; Cantekin EI; Bluestone CD; Welch RM; Cho YW
    Ann Otol Rhinol Laryngol; 1977; 86(2 pt. 1):235-42. PubMed ID: 322570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age.
    Wober W; Diez Crespo CD; Bähre M
    Arzneimittelforschung; 1997 Jul; 47(7):841-4. PubMed ID: 9272242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of the common cold.
    Supiyaphun P; Kerekhanjananarong V; Saengpanich S; Cutchavaree A
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S362-72. PubMed ID: 12930012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.
    Virchow JC; Bachert C
    Respir Med; 2006 Nov; 100(11):1952-9. PubMed ID: 16626955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A prospective multicenter randomized controlled clinical study on the efficacy and safety of Guaifenesin compound pseudoephedrine hydrochloride oral solution].
    ; Lu Q
    Zhonghua Er Ke Za Zhi; 2010 Mar; 48(3):204-7. PubMed ID: 20426957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An evaluation of triprolidine and pseudoephedrine in the treatment of allergic rhinitis.
    Diamond L; Gerson K; Cato A; Peace K; Perkins JG
    Ann Allergy; 1981 Aug; 47(2):87-91. PubMed ID: 7258744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of efficacy of management protocol in allergic rhinitis.
    Shah SA; Sajid T; Asif M; Khan F; Haroon T; Malik S; Ghani R
    J Ayub Med Coll Abbottabad; 2007; 19(3):6-9. PubMed ID: 18444581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cetirizine and pseudoephedrine retard alone and in combination in the treatment of perennial allergic rhinitis: a double-blind multicentre study.
    Bertrand B; Jamart J; Marchal JL; Arendt C
    Rhinology; 1996 Jun; 34(2):91-6. PubMed ID: 8876070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New treatment possibilities in obstructive respiratory tract diseases].
    Rambauske F
    Wien Med Wochenschr; 1971 Jan; 121(3):36-7. PubMed ID: 5545426
    [No Abstract]   [Full Text] [Related]  

  • 39. [Myoclonia caused by a combination of triprolidine, pseudoephedrine and paracetamol].
    Jacquesson M; Saudeau D; Pantin B; Girard JJ; Groussin P
    Nouv Presse Med; 1982 Jun; 11(30):2298-9. PubMed ID: 7110997
    [No Abstract]   [Full Text] [Related]  

  • 40. Common cold and influenza symptom management: the use of pharmacokinetic considerations to predict the efficacy of a twice-daily treatment for colds and flu.
    Stillings M; Little S; Sykes J
    Curr Med Res Opin; 2003; 19(8):791-9. PubMed ID: 14687451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.